Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

DEXA Scanning Recommendations for Endocrine Disorders and Osteoporosis Risk

Primary Indications for DEXA Scanning

  • The American College of Radiology recommends DEXA scanning for patients with Hashimoto's thyroiditis who have additional risk factors for osteoporosis, particularly if they are receiving long-term glucocorticoid therapy, as thyroid disorders are considered endocrine conditions that can adversely affect bone mineral density. 1

  • Patients with Hashimoto's thyroiditis who are receiving (or expected to receive) glucocorticoid therapy for >3 months should undergo DEXA scanning. 1, 2

  • DEXA scanning is indicated for patients with Hashimoto's who have an endocrine disorder known to adversely affect BMD (including hyperthyroidism, which may occur during periods of hashitoxicosis). 1

  • The American Academy of Family Physicians recommends DEXA scanning for postmenopausal women with Hashimoto's aged 65 years and older (standard recommendation for all women in this age group). 3

  • Postmenopausal women with Hashimoto's younger than 65 years who have additional risk factors for fracture should undergo DEXA scanning. 3

Risk Factors and Special Considerations

  • Additional risk factors that should prompt DEXA testing include: history of fragility fracture, body weight less than 127 lb (58 kg), and parental history of hip fracture. 3

  • The American College of Radiology recommends DEXA testing for patients with prolonged immobilization or malabsorption/malnutrition (which may occur with autoimmune comorbidities). 1

  • Follow-up DEXA scans should be performed every 1-2 years for patients on glucocorticoid therapy, and every 2 years for monitoring BMD changes in untreated patients with risk factors. 1

  • Z-scores (not T-scores) should be reported for premenopausal women and men under 50 with Hashimoto's, as they represent gender- and age-matched controls for evaluation of secondary osteoporosis. Z-scores of -2.0 or less are considered to be below the expected age range. 1

  • DXA lumbar spine and hip(s) is the primary recommended modality (rated 9/9 for appropriateness). 4

  • For patients with advanced degenerative changes of the spine, QCT lumbar spine and hip may be more appropriate. 6

Prevention and Treatment Guidelines

  • The American Academy of Family Physicians recommends the following daily dietary allowances for calcium and vitamin D:

    • Ages 19-50: 1,000 mg calcium, 600 IU vitamin D
    • Ages 51-70: 1,200 mg calcium, 600 IU vitamin D
    • Ages 71+: 1,200 mg calcium, 800 IU vitamin D 3
  • Lifestyle modifications including weight-bearing exercise, smoking cessation, and reducing alcohol intake are recommended for prevention. 3

  • Treatment is recommended for T-score of -2.5 or less. For T-scores between -1.0 and -2.5, FRAX can assist in making treatment decisions. 3

  • Treatment should also be considered in patients who have had a low-trauma fracture, even if DEXA does not indicate osteoporosis. 3